Wikidata

(Q36019213)

English

Combining fosamprenavir with lopinavir/ritonavir substantially reduces amprenavir and lopinavir exposure: ACTG protocol A5143 results

scientific article

In more languages

Statements

title
Combining fosamprenavir with lopinavir/ritonavir substantially reduces amprenavir and lopinavir exposure: ACTG protocol A5143 results (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
15668539
retrieved
11 August 2017
author name string
Angela Dm Kashuba
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
15668539
retrieved
11 August 2017
Camlin Tierney
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
15668539
retrieved
11 August 2017
Gerald F Downey
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
15668539
retrieved
11 August 2017
Edward P Acosta
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
15668539
retrieved
11 August 2017
Emanuel N Vergis
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
15668539
retrieved
11 August 2017
Karin Klingman
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
15668539
retrieved
11 August 2017
John W Mellors
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
15668539
retrieved
11 August 2017
Trevor R Scott
series ordinal
9
1 reference
stated in
Europe PubMed Central
PubMed ID
15668539
retrieved
11 August 2017
publication date
1 January 2005
1 reference
stated in
Europe PubMed Central
PubMed ID
15668539
retrieved
11 August 2017
page(s)
145-152
1 reference
stated in
Europe PubMed Central
PubMed ID
15668539
retrieved
11 August 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q36019213&oldid=1998908237"